Health Open for ApplicationsRFA-NS-26-001 Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
National Institutes of Health opportunity RFA-NS-26-001
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
National Institutes of HealthRFA-NS-26-001Grants.gov